A naukri.com initiative
Hitconsultant
4w
84
Image Credit: Hitconsultant
Glytec Secures $36M to Advance AI-Powered Diabetes Care and Inpatient Glycemic Management
- Glytec, a provider of AI-powered technology for diabetes care, secures a $36M growth investment led by Savitr Capital and Hayfin Capital Management.
- The funding will support the expansion of Glytec's platform, including Glucommander® SaaS solution, and the development of new technologies to improve inpatient glycemic control.
- The investment aligns with the growing need to enhance inpatient glycemic management as healthcare systems face pressure to improve performance with new CMS quality measures.
- Diabetes and related conditions continue to burden the healthcare system, with over one-third of hospitalized patients requiring insulin therapy.
- Poor management of high blood sugar leads to adverse events for over 2 million patients annually and costs the healthcare system more than $8 billion.
- Despite significant risks, many hospitals lack glucose management metrics and automated methods for tracking hyperglycemia and hypoglycemia rates.
- Glytec's Glucommander® SaaS solution, trusted by over 400 hospitals nationwide, aims to improve patient safety, reduce costs, and increase revenue through cloud-based insulin management.
- The new investment will be used to expand research and development efforts, scale the platform, and attract skilled talent to drive innovation.
- Glytec's CEO, Patrick Cua, views this investment as pivotal in empowering clinicians with data-driven insights for personalized care in diabetes and metabolic conditions.
Read Full Article
5 Likes
For uninterrupted reading, download the app